SILO

Silo Pharma, Inc. SILO

SILO
Silo Pharma, Inc. TOVX
Theriva Biologics, Inc. JAGX
Jaguar Health, Inc. SNGX
Soligenix, Inc. KTTA
Pasithea Therapeutics Corp. CMND
Clearmind Medicine Inc. INM
InMed Pharmaceuticals Inc. GRI
GRI Bio, Inc. CANF
Can-Fite BioPharma Ltd. CLDI
Calidi Biotherapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SILO TOVX JAGX SNGX KTTA CMND INM GRI CANF CLDI
6M -42.85 % -56.93 % -56.40 % -19.00 % -44.47 % 2.17 % -21.71 % 28.13 % -58.04 % -71.65 %
YTD -36.83 % -64.24 % -91.82 % -44.90 % -74.98 % -35.17 % -54.66 % -86.08 % -70.46 % -88.35 %
1Y -46.42 % -57.55 % -92.32 % -55.00 % -81.44 % -40.88 % -50.31 % -68.02 % -80.77 % -86.90 %
3Y -88.00 % -97.52 % -99.96 % -98.91 % -96.70 % -99.47 % -97.90 % -99.99 % -92.78 % -99.86 %
5Y 71.46 % -99.29 % -99.99 % -99.61 % -98.97 % -99.47 % -99.87 % -100.00 % -97.55 % -99.86 %
10Y 71.46 % -100.00 % -100.00 % -99.94 % -98.97 % -99.47 % -99.90 % -100.00 % -99.92 % -99.86 %
From the beginning 71.46 % -100.00 % -100.00 % -100.00 % -98.97 % -99.47 % -99.95 % -100.00 % -99.93 % -99.86 %

Dividend